By Iain Gilbert
Date: Friday 07 Mar 2025
(Sharecast News) - Life sciences firm Avacta revealed on Friday that it has agreed to sell its UK-based diagnostics unit to Duomed Belgium for £12.9m in cash.
By Josh White
Date: Thursday 16 Jan 2025
(Sharecast News) - Avacta Therapeutics announced promising results from its ongoing phase 1a trial of AVA6000 on Thursday, demonstrating meaningful tumour shrinkage in patients with salivary gland cancer (SGC).
By Michele Maatouk
Date: Thursday 21 Nov 2024
(Sharecast News) - Peel Hunt initiated coverage on Avacta on Thursday with a 'buy' rating and 99p price target as it pointed out three key aspects of the investment case.
Currency | UK Pounds |
Share Price | 27.50p |
Change Today | -0.75p |
% Change | -2.65 % |
52 Week High | 82.50 |
52 Week Low | 26.99 |
Volume | 1,981,230 |
Shares Issued | 386.87m |
Market Cap | £106.39m |
Beta | 0.05 |
RiskGrade | 461 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
17:07 | 52,750 @ 27.50p |
16:39 | 100,000 @ 28.00p |
16:24 | 5,000 @ 27.76p |
15:57 | 20,000 @ 27.21p |
15:45 | 17,943 @ 27.80p |
You are here: research